Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01252329 · ClinicalTrials.gov registry record · NA
Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)
A NA study, sponsored by University of Pittsburgh.
- Terminated
- Registry status
- NA
- Development phase
- 29
- Enrollment target
NCT01252329 is a NA study that was terminated before completion, run by University of Pittsburgh. The registered enrollment target is 29 participants.
The verdict
NCT01252329, a NA study, was terminated before completion, sponsored by University of Pittsburgh.
- TERMINATED
- Registry status
- NA
- Development phase
- 29 participants
- Enrollment target
Study Summary
This study will evaluate if there is a difference in survival between elective treatment of draining lymph nodes vs. clinical nodal observation in patients undergoing Mohs surgery for high risk skin squamous cell carcinoma of the head and neck who have a normal lymph node exam. Each treatment arm is accepted as a current standard of care, and the objective is to compare outcomes between the two arms.
Interventions
- PROCEDURE elective lymph node dissection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29 participants |
| Start Date | 2011-04 |
| Est. Completion | 2014-07-14 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01252329
The ClinicalTrials.gov registry entry for NCT01252329 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which elective lymph node dissection is the first listed.
NCT01252329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01252329 about?
NCT01252329 is a clinical study titled "Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)". This study will evaluate if there is a difference in survival between elective treatment of draining lymph nodes vs. clinical nodal observation in patients undergoing Mohs surgery for high risk skin squamous cell carcinoma of the head and neck who have a normal lymph node exam. Each treatment arm is...
What is the current status of trial NCT01252329?
This trial is currently terminated. It is a NA study. The enrollment target is 29 participants. The study started on 2011-04. Estimated completion is 2014-07-14.
What interventions are being tested in trial NCT01252329?
The interventions under investigation include: elective lymph node dissection (PROCEDURE).
Who is sponsoring clinical trial NCT01252329?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.